| Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu, B Zhang, ... Nature 593 (7857), 130-135, 2021 | 2289 | 2021 |
| Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 L Liu, S Iketani, Y Guo, JFW Chan, M Wang, L Liu, Y Luo, H Chu, Y Huang, ... Nature 602 (7898), 676-681, 2022 | 1191 | 2022 |
| Antibody evasion properties of SARS-CoV-2 Omicron sublineages S Iketani, L Liu, Y Guo, L Liu, JFW Chan, Y Huang, M Wang, Y Luo, J Yu, ... Nature 604 (7906), 553-556, 2022 | 775 | 2022 |
| Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, & BA.5 Q Wang, Y Guo, S Iketani, MS Nair, Z Li, H Mohri, M Wang, J Yu, ... Nature 608 (7923), 603-608, 2022 | 687 | 2022 |
| Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Q Wang, S Iketani, Z Li, L Liu, Y Guo, Y Huang, AD Bowen, M Liu, ... Cell 186 (2), 279-286, 2023 | 595 | 2023 |
| Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir S Iketani, H Mohri, B Culbertson, SJ Hong, Y Duan, MI Luck, ... Nature 613 (7944), 558-564, 2023 | 204 | 2023 |
| Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors S Iketani, F Forouhar, H Liu, SJ Hong, FY Lin, MS Nair, A Zask, Y Huang, ... Nature Communications 12 (1), 1-7, 2021 | 100 | 2021 |
| Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75 Q Wang, S Iketani, Z Li, Y Guo, AY Yeh, M Liu, J Yu, Z Sheng, Y Huang, ... Cell Host & Microbe 30 (11), 1512-1517, 2022 | 82 | 2022 |
| Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike Q Wang, Y Guo, L Liu, LT Schwanz, Z Li, MS Nair, J Ho, RM Zhang, ... Nature 624 (7992), 639-644, 2023 | 79 | 2023 |
| Influenza virus uses transportin 1 for vRNP debundling during cell entry Y Miyake, JJ Keusch, L Decamps, H Ho-Xuan, S Iketani, H Gut, U Kutay, ... Nature Microbiology 4 (4), 578-586, 2019 | 60 | 2019 |
| Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19 H Liu, S Iketani, A Zask, N Khanizeman, E Bednarova, F Forouhar, ... Nature Communications 13 (1), 1-16, 2022 | 57 | 2022 |
| Complex and dynamic interactions between parvovirus capsids, transferrin receptors, and antibodies control cell infection and host range HM Callaway, K Welsch, W Weichert, AB Allison, SL Hafenstein, K Huang, ... Journal of Virology 92 (13), e00460-18, 2018 | 41 | 2018 |
| CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models A Rathore, S Iketani, P Wang, M Jia, V Sahi, DD Ho Scientific Reports 10 (1), 1-14, 2020 | 39 | 2020 |
| A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses P Wang, RG Casner, MS Nair, J Yu, Y Guo, M Wang, JFW Chan, G Cerutti, ... Emerging Microbes & Infections 11 (1), 147-157, 2022 | 37 | 2022 |
| Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang, Q Bian, H Wang, H Sun, ... Nature 622 (7982), 376-382, 2023 | 34 | 2023 |
| An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses L Liu, S Iketani, Y Guo, ER Reddem, RG Casner, MS Nair, J Yu, ... Science Translational Medicine 14 (646), eabn6859, 2022 | 34 | 2022 |
| Near-atomic resolution structure of a highly neutralizing Fab bound to canine parvovirus LJ Organtini, H Lee, S Iketani, K Huang, RE Ashley, AM Makhov, ... Journal of Virology 90 (21), 9733-9742, 2016 | 33 | 2016 |
| Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites S Iketani, SJ Hong, J Sheng, F Bahari, B Culbertson, FF Atanaki, ... Cell Host & Microbe 30 (10), 1354-1362, 2022 | 32* | 2022 |
| Inhibitors of Coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity SJ Resnick, S Iketani, SJ Hong, A Zask, H Liu, S Kim, S Melore, FY Lin, ... Journal of Virology 95 (14), e02374-20, 2021 | 31 | 2021 |
| Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation S Iketani, RC Shean, M Ferren, N Makhsous, DB Aquino, A des Georges, ... mBio 9 (4), e00898-18, 2018 | 28 | 2018 |
